BETA: Please send your feedback!
Zogenix
ZGNX:NAS
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2021
—
About
Pharmaceuticals: Other
Founded 2006
Zogenix, Inc. is a pharmaceutical company, which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. It develops two products candidate: ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Cam L. Garner, MBA | Chairman | Male |
| Roger L. Hawley, CPA | Director | Male |
| Scott L. Glenn | Founder | Male |
| John J. Turanin, MBA | Founder | Male |
| Bret E. Megargel, MBA | Founder | Male |
| Jonathan M. N. Rigby, MBA | Founder | Male |
| Michael P. Smith, MBA | CFO, Secretary, Treasurer & Executive VP | Male |
| Stephen J. Farr, PhD | President, Chief Executive Officer & Director | Male |
| Edward F. Smith, III, PhD | Vice President-Regulatory Affairs & Drug Safety | Male |
| Bradley S. Galer, MD | Chief Medical Officer & Executive Vice President | Male |
Mindful Investing Summary
Zogenix - Competitors and Related Companies
How Zogenix stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Zogenix
ZGNX:NAS
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2021
—
Loading…